Cited 30 time in
Perspective on Intra-articular Injection Cell Therapy for Osteoarthritis Treatment
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Im, Gun-Il | - |
| dc.date.accessioned | 2023-04-28T03:40:43Z | - |
| dc.date.available | 2023-04-28T03:40:43Z | - |
| dc.date.issued | 2019-08 | - |
| dc.identifier.issn | 1738-2696 | - |
| dc.identifier.issn | 2212-5469 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/7872 | - |
| dc.description.abstract | BACKGROUND: Osteoarthritis (OA), the most common arthritis, is one of the most frequently encountered orthopaedic conditions. As a small number of large joints such as knee and hip are affected in OA, OA is an ideal target for local therapy. Although corticosteroid and hyaluronic acid have been traditionally used for joints through intra-articular (IA) injection, IA injection also provides a minimally invasive route to apply cell therapy to treat OA. IA cell therapy has drawn attention because it may provide regeneration of articular cartilage in addition to palliative anti-inflammatory effects. METHODS: Current progress of IA injection therapy and the author's perspective on this issue are described narratively. RESULTS: It is too premature to have any conclusion on the eventual efficacy of IA cell therapy concerning regeneration of articular cartilage based on current data. Prospective radiological and histological data from larger numbers of patients are needed to prove cost effectiveness of IA cell therapy. CONCLUSIONS: Expanding research in this field will produce further evidences to provide guidance on the eventual effectiveness of IA cell therapy in the future. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC | - |
| dc.title | Perspective on Intra-articular Injection Cell Therapy for Osteoarthritis Treatment | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s13770-018-00176-6 | - |
| dc.identifier.scopusid | 2-s2.0-85069898889 | - |
| dc.identifier.wosid | 000478634900005 | - |
| dc.identifier.bibliographicCitation | TISSUE ENGINEERING AND REGENERATIVE MEDICINE, v.16, no.4, pp 357 - 363 | - |
| dc.citation.title | TISSUE ENGINEERING AND REGENERATIVE MEDICINE | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 357 | - |
| dc.citation.endPage | 363 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002490854 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalResearchArea | Engineering | - |
| dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
| dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
| dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
| dc.subject.keywordPlus | STROMAL CELLS | - |
| dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
| dc.subject.keywordPlus | DRUG-DELIVERY | - |
| dc.subject.keywordPlus | BONE-MARROW | - |
| dc.subject.keywordPlus | KNEE | - |
| dc.subject.keywordPlus | CARTILAGE | - |
| dc.subject.keywordPlus | IMPLANTATION | - |
| dc.subject.keywordPlus | REPAIR | - |
| dc.subject.keywordAuthor | Cell therapy | - |
| dc.subject.keywordAuthor | Intra-articular injection | - |
| dc.subject.keywordAuthor | Cartilage regeneration | - |
| dc.subject.keywordAuthor | Osteoarthritis treatment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
